CSL
Director of Clinical Program, Immunoglobulins at CSL Behring will lead clinical strategy for immunoglobulin development programs within the company’s R&D organization. The role is based in King of Prussia, PA; Waltham, MA; Maidenhead, UK; or Zurich, Switzerland and is a hybrid position requiring onsite presence three days per week. The position operates in a project-led, collaborative biotech environment focused on developing innovative therapies for patients worldwide.
Headquarters
Melbourne, Victoria, Australia
Company Size
10001+ employees
Founded
1916
CSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL.
Clinical Scientist: Associate Director & Senior Manager, Tokyo
CSL Behring Australia
Director, Portfolio Development Process & Standards Lead
CSL Behring Australia
Associate Director, Patient Engagement Lead
CSL Behring Australia
Clinical Research Associate
ICON
Clinical Development Associate
Aurion Biotech
Senior Medical Writer (Remote)
MMS